213 related articles for article (PubMed ID: 35483879)
21. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
[TBL] [Abstract][Full Text] [Related]
22. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
24. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
[No Abstract] [Full Text] [Related]
25. Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.
Al-Saleem T; Wessner LL; Scheithauer BW; Patterson K; Roach ES; Dreyer SJ; Fujikawa K; Bjornsson J; Bernstein J; Henske EP
Cancer; 1998 Nov; 83(10):2208-16. PubMed ID: 9827727
[TBL] [Abstract][Full Text] [Related]
26. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma.
Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
Hum Pathol; 2023 Mar; 133():136-152. PubMed ID: 36894367
[TBL] [Abstract][Full Text] [Related]
27. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
Lam HC; Siroky BJ; Henske EP
Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
[TBL] [Abstract][Full Text] [Related]
28. Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.
Liu C; Lele SM; Goodenberger MH; Reiser GM; Christiansen AJ; Padussis JC
BMC Med Genomics; 2024 May; 17(1):144. PubMed ID: 38802873
[TBL] [Abstract][Full Text] [Related]
29. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma.
Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
Hum Pathol; 2022 Nov; 129():123-139. PubMed ID: 36115585
[TBL] [Abstract][Full Text] [Related]
30. [Tuberous sclerosis complex: A review].
Pfirmann P; Combe C; Rigothier C
Rev Med Interne; 2021 Oct; 42(10):714-721. PubMed ID: 33836894
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genes TSC1 and TSC2.
Maruyama H; Ohbayashi C; Hino O; Tsutsumi M; Konishi Y
Pathol Int; 2001 Aug; 51(8):585-94. PubMed ID: 11564212
[TBL] [Abstract][Full Text] [Related]
32. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort.
Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA
BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050
[TBL] [Abstract][Full Text] [Related]
33. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
34. Metastasis of benign tumor cells in tuberous sclerosis complex.
Henske EP
Genes Chromosomes Cancer; 2003 Dec; 38(4):376-81. PubMed ID: 14566858
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary lymphangioleiomyomatosis in a man.
Aubry MC; Myers JL; Ryu JH; Henske EP; Logginidou H; Jalal SM; Tazelaar HD
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):749-52. PubMed ID: 10934115
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype correlation of patients with tuberous sclerosis complex-associated renal angiomyolipoma: a descriptive study.
Li S; Zhang Y; Wang Z; Yang Y; Gao W; Li D; Wei J
Hum Pathol; 2018 Dec; 82():61-67. PubMed ID: 30036593
[TBL] [Abstract][Full Text] [Related]
37. Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients.
Habib SL
Mol Cancer; 2009 Mar; 8():13. PubMed ID: 19265534
[TBL] [Abstract][Full Text] [Related]
38. Angiomyolipoma have common mutations in TSC2 but no other common genetic events.
Qin W; Bajaj V; Malinowska I; Lu X; MacConaill L; Wu CL; Kwiatkowski DJ
PLoS One; 2011; 6(9):e24919. PubMed ID: 21949787
[TBL] [Abstract][Full Text] [Related]
39. Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of Apoptosis.
Unachukwu U; Sonett J; Woode D; Shiomi T; Chada K; D'Armiento JM
Mol Cancer Ther; 2023 Jul; 22(7):844-858. PubMed ID: 37127876
[TBL] [Abstract][Full Text] [Related]
40. TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.
Liu HJ; Lizotte PH; Du H; Speranza MC; Lam HC; Vaughan S; Alesi N; Wong KK; Freeman GJ; Sharpe AH; Henske EP
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
